PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 261 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $543,435 | -34.7% | 65,082 | +4.0% | 1.14% | -11.6% |
| Q2 2023 | $832,287 | -6.0% | 62,578 | -18.1% | 1.29% | -0.2% |
| Q1 2023 | $885,071 | +24.1% | 76,431 | -12.3% | 1.29% | +42.1% |
| Q4 2022 | $713,124 | -5.5% | 87,179 | -33.0% | 0.91% | +22.5% |
| Q3 2022 | $755,000 | +18.7% | 130,041 | -9.7% | 0.74% | +26.8% |
| Q2 2022 | $636,000 | +18.0% | 143,944 | +143.1% | 0.58% | +99.7% |
| Q1 2022 | $539,000 | -61.9% | 59,204 | -14.3% | 0.29% | -40.3% |
| Q4 2021 | $1,414,000 | -41.3% | 69,095 | -26.7% | 0.49% | -39.0% |
| Q3 2021 | $2,409,000 | +19.3% | 94,300 | +63.4% | 0.80% | +8.8% |
| Q2 2021 | $2,019,000 | +126.3% | 57,724 | +115.5% | 0.74% | +85.9% |
| Q1 2021 | $892,000 | – | 26,781 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |